Mutated EGFR-IN-1
Mutated EGFR-IN-1, an analog of Osimertinib, serves as a key chemical intermediate for developing inhibitors targeting oncogenic EGFR mutants including L858R, exon 19 deletions, and the resistant T790M variant. It is utilized in preclinical research for both in vitro enzymatic assays and in vivo efficacy studies in relevant xenograft models.
Product Specifications
CAS Number
1421372-66-8
Product Name Alternative
Mutated EGFRIN1, Mutated EGFR-IN-1, Mutated EGFR IN 1, inhibit, Osimertinib, Osimertinib analog, EGFR, EGFR (L858R), EGFR (T790M), EGFR (Exon 19 deletion/T790M), EGFRT790M, EGFRExon 19 deletion/T790M, EGFRL858R, Epidermal growth factor receptor, ErbB-1, Inhibitor, HER1
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Purity
98.91% (May vary between batches)
Solubility
DMSO:7.5 mg/mL (16.83 mM)
Smiles
COc1cc (N (C) CCN (C) C) c (N) cc1Nc1nccc (n1) -c1cn (C) c2ccccc12
Molecular Formula
C25H31N7O
Molecular Weight
445.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15083341 1 Vial
Lentiviral human SOX1 shRNA (UAS) - Lentiviral human SOX1 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details